In recent years, increasing studies have focused on the key regulatory roles of IL-1 family cytokines in innate and adaptive immunity, for example, the modulation of lymphocyte differentiation and function in the pathophysiology of human cancers, among which the anti-inflammatory cytokine IL-37 is highlighted. This evidence concerns the gene IL1A and cancer.